Health and Healthcare
Pfizer Ups Stock Buyback to $10 Billion
Published:
Last Updated:
In a sign that Pfizer Inc. (NYSE: PFE) has more cash on hand than the sense to use it wisely to create new drugs, its board approved a $10 billion share buyback. Pfizer has effectively cut costs, some via layoffs. R&D on new treatments is critical to the pharma company in a world of new age medicines, biotech and generics. Nonetheless, Pfizer believes it can increase shareholder returns by delivering cash the way that other public corporations like McDonald’s Corp. (NYSE: MCD) do. But a pharma company is not a fast-food chain.
Source: Wikimedia Commons
The company announced:
The board of directors of Pfizer Inc. today declared a 24-cent third-quarter 2013 dividend on the company’s common stock, payable September 4, 2013, to shareholders of record at the close of business on August 2, 2013. The third-quarter 2013 cash dividend will be the 299th consecutive quarterly dividend paid by Pfizer.
In addition, the board of directors has authorized a new $10 billion share repurchase program to be utilized over time. This new program is in addition to the $3.9 billion of authorization remaining under the company’s current share repurchase program.
Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
